2
Views
1
CrossRef citations to date
0
Altmetric
Symposium Issue: ADVANCES IN HEMATOLOGY

Platelet Disorders

Advances in Understanding and Management

, MD
Pages 50-56 | Published online: 07 Jul 2016

REFERENCES

  • Marcus AJ: Platelet function. N Engl J Med 280:1213, 1969
  • Ginsburg AD, Aster RH: Platelet function? Its clinical significance. DM, Sept 1970
  • Packham MA, Mustard JF: Platelet reactions. Semin Hematol 8:30, 1971
  • Weiss HJ: The pharmacology of platelet inhibition. In Spaet TH (Editor): Progress in Hemostasis and Thrombosis. New York, Grune & Stratton, Inc, 1972, p 199
  • Hohnsen H: The platelet: Its membrane, physiology and biochemistry. Clinics Haematol 1:235, 1972
  • Walsh PN: The role of platelets in the contact phase of blood coagulation. Br J Haematol 22:237, 1972
  • Gimbrone MA Jr, Aster RH, Cotran RS, et al: Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 221:33, 1969
  • Clawson CC, White JG: Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol 65:381, 1971
  • Nachman RL, Weksler B, Ferris B: Increased vascular permeability produced bv human platelet granule cationic extract. J Clin Invest 49:274, 1970
  • Weksler BB, Coupal CE: Platelet-dependent generation of chemotactic activity in serum. J Exp Med 137:1419, 1973
  • Weiss HJ: Bleeding disorders due to abnormal platelet function. Med Clin North Am 57:517, 1973
  • tenCate JW: Platelet function tests. Clinics Haematol 1:283, 1972
  • Cowan DH, Haut MJ: Platelet function in acute leukemia. J Lab Clin Med 79:893, 1972
  • Mills DC: Drugs that affect platelet behavior. Clinics Haematol 1:295, 1972
  • Kaneshiro MM, Mielke CH Jr, Kasper CK, et al: Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med 281:1039, 1969
  • Harker LA, Slichter SJ: Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med 283:1302, 1970
  • Salzman EW, Harris WH, DeSanctis RW: Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med 284:1287, 1971
  • Sullivan JM, Harken DE, Gorlin R: Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med 284:1391, 1971
  • Aster RH: Thrombocytopenia due to enhanced platelet destruction. In Williams WJ, Buetler E, Erslev AJ, et al (Editors): Hematology. New York, McGraw-Hill Book Company, 1972, p 1131
  • Eisner EV, Shahidi NT: Immune thrombocytopenia due to a drug metabolite. N Engl J Med 287:376, 1972
  • Karpatkin S, Strick N, Karpatkin MB, et al: Cumulative experience in the detection of anti-platelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 52:776, 1972
  • Clancy R: Cellular immunity to autologous platelets and serum-blocking factors in idiopathic thrombocytopenic purpura. Lancet 1:6, 1972
  • Amir J, Krauss S: Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs. Blood 42:27, 1973
  • Cash JD: Platelet transfusion therapy. Clinics Haematol 1:395, 1972
  • Yankee RA, Graff KS, Dowling R, et al: Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N Engl J Med 288:760, 1973

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.